Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|
| 1 | 2 | |||
| Alopecia | x | x | ||
| Refractory anemia | x | |||
| Anorexia | x | |||
| Ataxia | x | x | ||
| Infection | x | |||
| Contusion | x | |||
| Dysarthria | x | x | ||
| Body temperature increased | x | |||
| Fibrosis | x | x | ||
| Haemorrhage | x | |||
| Lethargy | x | x | ||
| Leukopenia | x | x | ||
| Nausea | x | x | ||
| Neoplasm | x | x | ||
| Optic atrophy | x | |||
| Pancytopenia | x | |||
| Pulmonary fibrosis | x | x | ||
| Renal failure | x | x | ||
| Stomatitis | x | x | ||
| Thrombocytopenia | x | x | ||
| Vomiting | x | x | ||
| Acute leukaemia | x | x | ||
| Disorientation | x | x | ||
| Neurologic reaction | x | |||
| Hepatotoxicity | x | |||
| Lung infiltration | x | x | ||
| Throat sore | x | |||
| Azotaemia | x | x | ||
| Dysplasia | x | x | ||
| Blindness | x | |||
| Visual disturbance | x | |||
| Nephrotoxicity | x | |||
| Myelosuppression | x | x | ||
| Pulmonary toxicity | x | x | ||
| Gastrointestinal toxicity | x | |||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||
|---|---|---|---|---|
| Anaemia | x | |||
| Brain neoplasm | x | x | ||
| Hodgkin's disease | x | x | ||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |